Skip to main content

The Economy Wiki

[email protected]

The Economy Wiki

The Economy Wiki

Vetter is an established healthcare institution whose principal relevance to this ranking lies in aseptic fill-finish and injectable drug manufacturing. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biomanufacturing & CDMO Providers.

Read More
The Economy Wiki

Verve Therapeutics is a clinical-stage company developing genetic medicines for cardiovascular disease; Eli Lilly and Company completed its acquisition on 25 July 2025. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in cell & Gene Therapy Developers.

Read More
The Economy Wiki

Vertex Pharmaceuticals is one of the most strategically important biotechnology firms globally, with a dominant position in cystic fibrosis and expanding activity in gene editing, pain medicine, kidney disease, and other genetically or biologically defined conditions. Biotechnology Firms Overview

Read More
The Economy Wiki

Veristat is a specialist contract research organization whose principal relevance to this ranking lies in biostatistics, regulatory and clinical development for complex therapies. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in contract Research Organizations.

Read More
The Economy Wiki

Vaxcyte is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 2 ranking categories Overview Vaxcyte is an institution recognized in the 2026 Ranking News professional-ranking universe.

Read More
The Economy Wiki

Valneva is a specialty vaccine company whose principal relevance to this ranking lies in vaccine & immunotherapy developers. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.

Read More
The Economy Wiki

United Therapeutics is an established biotechnology firm focused on pulmonary arterial hypertension and related rare cardiopulmonary diseases, with additional long-term activity in organ manufacturing and transplant-related technologies. Biotechnology Firms Overview

Read More
The Economy Wiki

uniQure is one of the pioneering companies in gene therapy, with a history in AAV-based therapeutic development. The company is associated with some of the earliest gene therapy milestones in Europe and has remained active in hemophilia and neurological gene therapy.

Read More
The Economy Wiki

Ultragenyx Pharmaceutical is a specialist rare disease company focused on serious genetic and metabolic disorders. Its portfolio includes therapies for rare skeletal, metabolic, and genetic diseases, with additional development activity in gene therapy and biologically targeted treatments.

Read More
The Economy Wiki

UCB is one of Europe’s most important specialty pharmaceutical companies, with a focused strategy in neurology and immunology. The company has built strong franchises in epilepsy, movement disorders, inflammatory disease, and specialist-managed chronic conditions.

Read More
The Economy Wiki

TScan Therapeutics is a clinical-stage biotechnology company developing T-cell receptor-engineered T-cell therapies for cancer. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in cell & Gene Therapy Developers.

Read More
The Economy Wiki

Travere Therapeutics is an established healthcare institution whose principal relevance to this ranking lies in rare kidney and metabolic disease medicines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.

Read More
The Economy Wiki

Tigermed is an established healthcare institution whose principal relevance to this ranking lies in global clinical research with substantial Asia-based delivery. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in contract Research Organizations.

Read More
The Economy Wiki

Teva Pharmaceutical Industries Ltd. is a biopharmaceutical company with innovative medicines, generic pharmaceuticals and biosimilars. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in global Pharmaceutical Companies.

Read More
The Economy Wiki

Takeda Pharmaceutical is an established healthcare institution whose principal relevance to this ranking lies in global pharmaceutical companies. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in global Pharmaceutical Companies.

Read More
The Economy Wiki

Syneos Health is one of the major global CROs, combining clinical development services with commercial, consulting, and medical affairs capabilities. Its model is built around supporting sponsors from development through commercialization, making it relevant across the full product lifecycle.

Read More
The Economy Wiki

Swedish Orphan Biovitrum, commonly known as Sobi, is one of Europe’s most important rare disease and orphan drug companies. The company focuses on rare hematology, immunology, and specialty care, with a portfolio designed for specialist-managed diseases.

Read More
The Economy Wiki

Supernus Pharmaceuticals is an established healthcare institution whose principal relevance to this ranking lies in central nervous system specialty medicines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in specialty Pharma Companies.

Read More
The Economy Wiki

Stoke Therapeutics is an established healthcare institution whose principal relevance to this ranking lies in RNA-based medicines for severe genetic diseases. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.

Read More
The Economy Wiki

Soleno Therapeutics is a Neurocrine Biosciences company focused on developing and commercializing treatments for rare diseases, including Prader-Willi syndrome. Neurocrine completed its acquisition of Soleno on 18 May 2026. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.

Read More